The Novel FAT4 Activator Jujuboside A Suppresses NSCLC Tumorigenesis by Activating HIPPO Signaling and Inhibiting YAP Nuclear Translocation

Publication date: Available online 9 June 2021Source: Pharmacological ResearchAuthor(s): Wensheng Wang, Qiuju Huang, Yao Chen, Zhiying Huang, Yanfang Huang, Ying Wang, Xiaoxiao Qi, Zhongqiu Liu, Linlin Lu
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research